Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain
Abstract Cannabigerol (CBG), derived from the cannabis plant, acts as an acute analgesic in a model of cisplatin-induced peripheral neuropathy…
Kent E. Vrana
CANNabinoid Drug Interaction Review (CANN-DIR™)
Abstract Non-prescription cannabidiol (CBD) and medical marijuana (cannabis) currently do not have US Food and Drug Administration (FDA)-approved prescribing information…
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain
Abstract (1) Background: Recently, a number of side chain length variants for tetrahydrocannabinol and cannabidiol have been identified in cannabis;…
Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy
Abstract Cannabis is a complex biosynthetic plant, with a long history of medicinal use. While cannabinoids have received the majority…
Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
Abstract Neuropathic pain is a condition that impacts a substantial portion of the population and is expected to affect a…
Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents
Abstract We report 3 adolescents with cannabis hyperemesis syndrome and recurrent hypophosphatemia complicating their clinical course with potential for significant…
Acute Cannabigerol Administration Lowers Blood Pressure in Mice
Abstract Cannabigerol is a cannabinoid compound synthesized by Cannabis sativa, which in its acid form acts as the substrate for…
Synthetic Cannabinoid Activity Against Colorectal Cancer Cells
Abstract Introduction: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, and new therapeutic strategies are still required.…